News

Brain abscess with lung infection? Think Nocardia
ST. LOUIS – Patients don’t have to be immunosuppressed.
ST. LOUIS – Patients don’t have to be immunosuppressed.
PARIS – Prescient childhood cohort studies launched in the 1970s are paying off.
SAN ANTONIO – First U.S. phase 3 trial for eosinophilic esophagitis hits all endpoints.
SAN ANTONIO – Exposure to fresh red cells may be associated with immune suppression because viable white cells may also be present in the product...
NEW ORLEANS – Common patient-related barriers include poor understanding of how the medication may help and how to...
Levofloxacin looks like a promising addition to therapy, but the researchers cautioned that antibiotic resistance must be considered.
PARIS – PARAGON-HF’s primary endpoint was neutral, but desperation for a HFpEF therapy highlights a subgroup analysis.